APGN

COM:APEXIGEN

Pyxis Oncology

  • Stock

Last Close

0.35

22/08 19:59

Market Cap

9.57M

Beta: -

Volume Today

94.43K

Avg: -

  • locale

    usUnited States
  • market

    STOCKS
  • industry

    Biotechnology & Pharmaceuticals
  • website

    www.apexigen.com
  • ipo date

    Feb 22, 2021

Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian ...Show More

peer of